Home » Cancer Articles » Patience recruitment for oncological clinical trials: seminar by Jai Balkissoon, from Oxigene
Patience recruitment for oncological clinical trials: seminar by Jai Balkissoon, from Oxigene
Jai Balkisson, Senior Medical Director, Oncology from Oxigene will lead the session focused on establishing a multidisciplinary network to improve patience take up and assess the eligibility at Optimising Clinical Development in Oncology conference.
LONDON, ENGLAND, December 18, 2010 /Cancer PR News/ -- One of the most fundamental issues related to oncological clinical trials is arguably patient recruitment. Scott Connor, vice-president of marketing at patient recruitment specialist Acurian, told the news provider that, like most things in life, finance is a key first step. "It can be difficult for study teams to get sufficient funding for retention strategies, even though the impact of losing patients post-enrolment is high," he explained.
Jai will discuss how developing a strong relationship with hospitals and physicians can be crucial for patience recruitment. He will showcase different routes of forming the relationships with patience: partnerships and networks with non-industry organisations, understanding patients' motivations and apprehensions through communication with physicians and developing a recruitment strategy with your trial partner.
Patience recruitment is one of the workshops taking place as a part of the Optimising Clinical Development in Oncology conference. The meeting gathering 18 industry experts will focus on ideas how to:
-Maximise the efficiency of your clinical development through implementing innovative trial design approaches
-Facilitate go/no-go decisions, assess tumour response and achieve patient stratification through effective application of biomarkers and companion diagnostics
-Understand and applying functional imaging techniques for tumour assessment at the molecular level and drive drug development
-Realise the potential of personalised medicine through efficient patient stratification
-Speed time to market through implementation of the new ICH S9 guideline
Optimising Clinical Development in Oncology is co-located with Optimising Clinical Development for CNS as a part of Clinical Trials Summit. To see the final speaker line-up, please go to www.oncologysummit.co.uk or www.clinicalcns.co.uk.
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community
Through Pharma IQ, you will be able to access pharmaceutical information resources such as presentations and podcasts, as well as events such as webinars, seminars and conferences.
By signing up to the Pharma IQ membership, you will gain access to our growing database of multimedia presentations from leading pharma practitioners, weekly newsletters to keep you updated on latest pharmaceutical content and Pharma IQ members-exclusive discounts on pharma events that offer solutions to your everyday business problems.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Joanna Checinska
Defence IQ
Marketing Manager
129 Wilton Road
London, London
United Kingdom SW1V 1JZ
Voice: 02073689421
Website: Visit Our Website |
|
|
|
|
|
|
Advertise With Us |
About Us |
Contact Us